Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26)

Journal of Immunology

Volumn 188, Issue 11, 2012, Pages 5438-5447

  Bengsch, Bertram ^a,b   Seigel, Bianca ^a,b   Flecken, Tobias ^a,b   Wolanski, Julia ^a   Blum, Hubert E ^a   Thimme, Robert ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; DIPEPTIDYL PEPTIDASE IV; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 22; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENTERITIS; FLOW CYTOMETRY; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE DIFFERENTIATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; TH2 CELL;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DIPEPTIDYL PEPTIDASE 4; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-17; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS; UP-REGULATION;

EID: 84862067258     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103801     Document Type: Article

References (40)

1. Miossec, P., T. Korn, and V. K. Kuchroo. 2009. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361: 888-898.
2. Zenewicz, L. A., and R. A. Flavell. 2008. IL-22 and inflammation: leukin'through a glass onion. Eur. J. Immunol. 38: 3265-3268.
3. Mitsdoerffer, M., Y. Lee, A. Jäger, H. J. Kim, T. Korn, J. K. Kolls, H. Cantor, E. Bettelli, and V. K. Kuchroo. 2010. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. USA 107: 14292-14297.
4. Pelletier, M., L. Maggi, A. Micheletti, E. Lazzeri, N. Tamassia, C. Costantini, L. Cosmi, C. Lunardi, F. Annunziato, S. Romagnani, and M. A. Cassatella. 2010. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115: 335-343.
5. Damsker, J. M., A. M. Hansen, and R. R. Caspi. 2010. Th1 and Th17 cells: adversaries and collaborators. Ann. N. Y. Acad. Sci. 1183: 211-221.
6. Zou, W., and N. P. T. Restifo. 2010. TH17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 10: 248-256.
7. + T cell precursor. J. Exp. Med. 205: 1903-1916.
8. Maggi, L., V. Santarlasci, M. Capone, A. Peired, F. Frosali, S. Q. Crome, V. Querci, M. Fambrini, F. Liotta, M. K. Levings, et al. 2010. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 40: 2174-2181.
9. Ohnuma, K., N. H. Dang, and C. Morimoto. 2008. Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol. 29: 295-301.
10. Ellingsen, T., N. Hornung, B. K. Møller, J. Hjelm-Poulsen, and K. Stengaard- Pedersen. 2007. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4+ T lymphocytes. Scand. J. Immunol. 66: 451-457. (Pubitemid 47394557)
11. + memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis. J. Neuroimmunol. 181: 157-164.
12. Jensen, J., A. R. Langkilde, C. Fenst, M. S. Nicolaisen, H. G. Roed, M. Christiansen, and F. Sellebjerg. 2004. CD4 T cell activation and disease activity at onset of multiple sclerosis. J. Neuroimmunol. 149: 202-209. (Pubitemid 38352874)
13. +T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-β treatment. J. Neuroimmunol. 179: 163-172.
14. Matteucci, E., and O. Giampietro. 2009. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr. Med. Chem. 16: 2943-2951.
15. Proost, P., E. Schutyser, P. Menten, S. Struyf, A. Wuyts, G. Opdenakker, M. Detheux, M. Parmentier, C. Durinx, A. M. Lambeir, et al. 2001. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98: 3554-3561.
16. Shioda, T., H. Kato, Y. Ohnishi, K. Tashiro, M. Ikegawa, E. E. Nakayama, H. Hu, A. Kato, Y. Sakai, H. Liu, et al. 1998. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc. Natl. Acad. Sci. USA 95: 6331-6336. (Pubitemid 28249012)
17. Christopherson, K. W., II, G. Hangoc, C. R. Mantel, and H. E. Broxmeyer. 2004. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305: 1000-1003. (Pubitemid 39071774)
18. + T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J. Virol. 81: 945-953.
19. + T cells defines a distinct functional subset with tissue-homing properties. Proc. Natl. Acad. Sci. USA 107: 3006-3011.
20. Wilke, C. M., K. Bishop, D. Fox, and W. Zou. 2011. Deciphering the role of Th17 cells in human disease. Trends Immunol. 32: 603-611.
21. Beriou, G., E. M. Bradshaw, E. Lozano, C. M. Costantino, W. D. Hastings, T. Orban, W. Elyaman, S. J. Khoury, V. K. Kuchroo, C. Baecher-Allan, and D. A. Hafler. 2010. TGF-β induces IL-9 production from human Th17 cells. J. Immunol. 185: 46-54.
22. + T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum. 63: 2504-2515.
23. Kesselring, R., A. Thiel, R. Pries, and B. Wollenberg. 2011. The number of CD161 positive Th17 cells are decreased in head and neck cancer patients. Cell. Immunol. 269: 74-77.
24. Kleinschek, M. A., K. Boniface, S. Sadekova, J. Grein, E. E. Murphy, S. P. Turner, L. Raskin, B. Desai, W. A. Faubion, R. de Waal Malefyt, et al. 2009. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 206: 525-534.
25. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filì, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861. (Pubitemid 47240944)
26. Hammerich, L., F. Heymann, and F. Tacke. 2011. Role of IL-17 and Th17 cells in liver diseases. Clin. Dev. Immunol. 2011: 345803.
27. Hu, Y., F. Shen, N. K. Crellin, and W. Ouyang. 2011. The IL-17 pathway as amajor therapeutic target in autoimmune diseases. Ann. N. Y. Acad. Sci. 1217: 60-76.
28. Peters, A., Y. Lee, and V. K. Kuchroo. 2011. The many faces of Th17 cells. Curr. Opin. Immunol. 23: 702-706.
29. Haak, S., A. L. Croxford, K. Kreymborg, F. L. Heppner, S. Pouly, B. Becher, and A. Waisman. 2009. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119: 61-69.
30. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
31. H17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568-575.
32. Nistala, K., S. Adams, H. Cambrook, S. Ursu, B. Olivito, W. de Jager, J. G. Evans, R. Cimaz, M. Bajaj-Elliott, and L. R. Wedderburn. 2010. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl. Acad. Sci. USA 107: 14751-14756.
33. Hirota, K., J. H. Duarte, M. Veldhoen, E. Hornsby, Y. Li, D. J. Cua, H. Ahlfors, C. Wilhelm, M. Tolaini, U. Menzel, et al. 2011. Fate mapping of IL-17- producing T cells in inflammatory responses. Nat. Immunol. 12: 255-263.
34. Boniface, K., W. M. Blumenschein, K. Brovont-Porth, M. J. McGeachy, B. Basham, B. Desai, R. Pierce, T. K. McClanahan, S. Sadekova, and R. de Waal Malefyt. 2010. Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage. J. Immunol. 185: 679-687.
35. Liu, Z. J., P. K. Yadav, J. L. Su, J. S. Wang, and K. Fei. 2009. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J. Gastroenterol. 15: 5784-5788.
36. Morrison, P. J., S. J. Ballantyne, and M. C. Kullberg. 2011. Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity. Immunology 133: 397-408.
37. Bromley, S. K., T. R. Mempel, and A. D. Luster. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9: 970-980.
38. Harper, E. G., C. Guo, H. Rizzo, J. V. Lillis, S. E. Kurtz, I. Skorcheva, D. Purdy, E. Fitch, M. Iordanov, and A. Blauvelt. 2009. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J. Invest. Dermatol. 129: 2175-2183.
39. Casrouge, A., J. Decalf, M. Ahloulay, C. Lababidi, H. Mansour, A. Vallet- Pichard, V. Mallet, E. Mottez, J. Mapes, A. Fontanet, et al. 2011. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J. Clin. Invest. 121: 308-317.
40. Cordero, O. J., F. J. Salgado, and M. Nogueira. 2009. On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunol. Immunother. 58: 1723-1747.